{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
Search results for "ORPHAN DRUG|Designated/Withdrawn" in comments (approximate match)
Status:
Investigational
Source:
NCT00462904: Phase 2 Interventional Terminated Burns
(2006)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT02289898: Phase 2 Interventional Completed Pancreatic Cancer
(2015)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT01355614: Phase 2 Interventional Completed Crohn's Disease
(2011)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT01204749: Phase 3 Interventional Completed Fallopian Tube Cancer
(2010)
Source URL:
Class:
PROTEIN
Class:
PROTEIN
Status:
Investigational
Source:
NCT00323518: Phase 2 Interventional Completed Oral Mucositis
(2006)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT00103545: Phase 1/Phase 2 Interventional Completed Ovarian Cancer
(2003)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT02137343: Phase 3 Interventional Terminated Gastric Cancer
(2014)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT00670592: Phase 1/Phase 2 Interventional Completed Non-Hodgkin's Lymphoma
(2008)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT00322270: Phase 3 Interventional Completed Thrombosis
(2006)
Source URL:
Class:
PROTEIN